The selective alpha-adrenergic receptor agonist dexmedetomidine (DEX) does not affect aortic pressure augmentation

2005 ◽  
Vol 77 (2) ◽  
pp. P11-P11
Author(s):  
D KURNIK ◽  
G SOFOWORA ◽  
M MUSZKAT ◽  
P HARRIS ◽  
A WOOD ◽  
...  
Keyword(s):  
Adrenergic Receptor ◽  
Receptor Agonist ◽  
Aortic Pressure ◽  
Alpha Adrenergic Receptor ◽  
Adrenergic Receptor Agonist

Apraclonidine in the unlicensed treatment of eyelid ptosis

2019 ◽  
Vol 8 (6) ◽  
pp. 262-265
Author(s):  
Gemma Fromage
Keyword(s):  
Adrenergic Receptor ◽  
Receptor Agonist ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
Injection Technique ◽  
Alpha Adrenergic Receptor ◽  
Increased Risk ◽  
Facial Anatomy ◽  
Adrenergic Receptor Agonist ◽  
Müller’S Muscle

Eyelid ptosis is a complication that may occur following injection of botulinum toxin type A. It generally presents within 3–7 days of treatment. A drooping or lowering of the eyelid may be severe to the point that it leads to restriction of vision, or it may be subtle, with just the feeling of a heavy lid or, more typically, difficulty in being able to apply eye make-up. There is currently no licensed treatment for eyelid ptosis. Apraclonidine hydrochloride, commonly known as Iopidine is an alpha-adrenergic receptor agonist and causes the contraction of the Muller's muscle, which may result in an eyelid lift of 1–3 mm. There are factors that may lead to an increased risk of this complication, and there are also ways in which to help prevent it from occurring. Thorough consultations should always be given and practitioners should always ensure that they have in-depth knowledge of facial anatomy and musculature and use good injection technique.

Physiological Responses to Daily Use of Beta-Three Adrenergic Receptor Agonist, Mirabegron

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1146-P
Author(s):  
ALANA O'MARA ◽  
AARON CYPESS ◽  
CHERYL CERO ◽  
JAMES W. JOHNSON ◽  
JOYCE D. LINDERMAN ◽  
...  
Keyword(s):  
Adrenergic Receptor ◽  
Receptor Agonist ◽  
Physiological Responses ◽  
Adrenergic Receptor Agonist

scholarly journals Long-acting β2-adrenergic receptor agonist in pediatric asthma

2004 ◽  
Vol 53 (2) ◽  
pp. 69-75 ◽  
Author(s):  
Shigemi Yoshihara ◽  
Yumi Yamada ◽  
Toshio Abe ◽  
Osamu Arisaka
Keyword(s):  
Adrenergic Receptor ◽  
Receptor Agonist ◽  
Pediatric Asthma ◽  
Β2 Adrenergic Receptor ◽  
Long Acting ◽  
Adrenergic Receptor Agonist

scholarly journals Effect of Procaterol, a β2 Selective Adrenergic Receptor Agonist, on Airway Inflammation and Hyperresponsiveness

2007 ◽  
Vol 56 (3) ◽  
pp. 241-247 ◽  
Author(s):  
Hiroyuki Tashimo ◽  
Naomi Yamashita ◽  
Hirofumi Ishida ◽  
Hiroyuki Nagase ◽  
Tetsuya Adachi ◽  
...  
Keyword(s):  
Airway Inflammation ◽  
Adrenergic Receptor ◽  
Receptor Agonist ◽  
Adrenergic Receptor Agonist
Sign in / Sign up

Export Citation Format

Share Document